Molecular Pathways: Receptor Ectodomain Shedding in Treatment, Resistance, and Monitoring of Cancer
Proteases known as sheddases cleave the extracellular domains of their substrates from the cell surface. The A Disintegrin and Metalloproteinases ADAM10 and ADAM17 are among the most prominent sheddases, being widely expressed in many tissues, frequently overexpressed in cancer, and promiscuously cl...
Main Authors: | Miller, Miles A., Sullivan, Ryan J., Lauffenburger, Douglas A |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering |
Format: | Article |
Published: |
American Association for Cancer Research (AACR)
2018
|
Online Access: | http://hdl.handle.net/1721.1/117690 https://orcid.org/0000-0002-0050-989X |
Similar Items
-
Functional Genomics Approach Identifies Novel Signaling Regulators of TGFα Ectodomain Shedding
by: Kefaloyianni, Eirini, et al.
Published: (2019) -
Role of glycosylation in EGFR ectodomain interactions : a molecular dynamics study
by: Azimzadeh Irani, Maryam
Published: (2017) -
The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells
by: Meyer, Aaron Samuel, et al.
Published: (2014) -
ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling
by: Miller, Miles Aaron, et al.
Published: (2013) -
Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron
by: Teng, I-Ting, et al.
Published: (2022)